Robey, Robert W.
National Cancer Institute (NCI),
United States
2025 Rank: 141779
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 4299 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 141779 | 154469 |
| Total Cites | 648 | 720 |
| H-index | 10 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 301 | 317 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 303 | 319 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 520 | 546 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.32 |
| Self-Citation Percentage |
10.00%
|
|
Robey, Robert W.
National Institutes of Health (NIH),
United States
2024 Rank: 146961
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 4816 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 146961 | 160750 |
| Total Cites | 651 | 694 |
| H-index | 10 | 10 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 300 | 308 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 304 | 312 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 516 | 534 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.30 |
| Self-Citation Percentage |
6.20%
|
|
Robey, Robert W.
National Cancer Institute (NCI),
United States
2023 Rank: 108526
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3863 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 108526 | 119974 |
| Total Cites | 726 | 791 |
| H-index | 11 | 11 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 343 | 354 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 348 | 359 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 594 | 608 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.30 |
| Self-Citation Percentage |
8.22%
|
|
Robey, Robert W.
National Cancer Institute (NCI),
United States
2022 Rank: 81626
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3100 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81626 | 89017 |
| Total Cites | 825 | 892 |
| H-index | 12 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 379 | 396 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 381 | 399 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 616 | 632 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.41 |
| Self-Citation Percentage |
7.51%
|
|
Robey, Robert W.
National Cancer Institute (NCI),
United States
2021 Rank: 86942
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3123 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86942 | 94054 |
| Total Cites | 1140 | 1241 |
| H-index | 15 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 546 | 564 |
| Number of Single+First+Last Authored Papers | 21 | 21 |
| Total Cites to Single+First+Last Authored Papers | 546 | 564 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 841 | 878 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.41 |
| Self-Citation Percentage |
8.14%
|
|
Robey, Robert W.
National Cancer Institute,
United States
2020 Rank: 110135
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3833 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 110135 | 117628 |
| Total Cites | 714 | 807 |
| H-index | 13 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 294 | 311 |
| Number of Single+First+Last Authored Papers | 21 | 21 |
| Total Cites to Single+First+Last Authored Papers | 296 | 314 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 542 | 579 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.39 |
| Self-Citation Percentage |
11.52%
|
|